$1.25 Billion is the total value of FRAZIER MANAGEMENT LLC's 41 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 26.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $201,494,000 | -12.5% | 8,434,232 | 0.0% | 16.12% | -24.0% | |
| PHAT | PHATHOM PHARMACEUTICALS INC | $187,060,000 | -5.2% | 5,827,415 | 0.0% | 14.97% | -17.7% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $71,053,000 | +15.2% | 3,566,912 | 0.0% | 5.68% | -0.1% | |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $65,948,000 | +18.5% | 2,674,299 | +25.1% | 5.28% | +2.9% |
| New | IMAGO BIOSCIENCES INC | $59,515,000 | – | 2,971,274 | +100.0% | 4.76% | – | |
| PCVX | VAXCYTE INC | $58,593,000 | +12.7% | 2,309,554 | 0.0% | 4.69% | -2.2% | |
| TRILLIUM THERAPEUTICS INC | $54,984,000 | +81.6% | 3,123,107 | 0.0% | 4.40% | +57.6% | ||
| GRTS | Buy | GRITSTONE BIO INC | $50,406,000 | +435.6% | 4,667,242 | +352.7% | 4.03% | +364.6% |
| PASG | PASSAGE BIO INC | $49,892,000 | -24.8% | 5,009,219 | 0.0% | 3.99% | -34.7% | |
| KRYS | Sell | KRYSTAL BIOTECH INC | $40,267,000 | -24.8% | 771,250 | -2.1% | 3.22% | -34.8% |
| TARS | TARSUS PHARMACEUTICALS INC | $30,540,000 | -25.6% | 1,417,157 | 0.0% | 2.44% | -35.5% | |
| ISEE | Sell | IVERIC BIO INC | $29,856,000 | +85.9% | 1,838,402 | -27.7% | 2.39% | +61.3% |
| STRO | Buy | SUTRO BIOPHARMA INC | $27,743,000 | +49.0% | 1,468,663 | +46.7% | 2.22% | +29.3% |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $24,761,000 | – | 1,505,200 | +100.0% | 1.98% | – |
| ANAB | ANAPTYSBIO INC | $24,400,000 | +4.6% | 899,700 | 0.0% | 1.95% | -9.3% | |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $23,126,000 | +52.5% | 3,530,657 | +54.6% | 1.85% | +32.2% |
| SNDX | SYNDAX PHARMACEUTICALS INC | $22,705,000 | +11.3% | 1,188,135 | 0.0% | 1.82% | -3.4% | |
| New | TYRA BIOSCIENCES INC | $21,988,000 | – | 1,250,000 | +100.0% | 1.76% | – | |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $21,334,000 | +37.4% | 1,671,918 | +52.0% | 1.71% | +19.2% |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $18,906,000 | -18.3% | 1,771,844 | -31.1% | 1.51% | -29.1% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $18,419,000 | – | 442,880 | +100.0% | 1.47% | – |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $17,920,000 | – | 851,306 | +100.0% | 1.43% | – |
| SRRA | Buy | SIERRA ONCOLOGY INC | $17,638,000 | +346.6% | 804,667 | +296.8% | 1.41% | +287.6% |
| FLACU | FRAZIER LIFESCIENCES ACQU COunit 12/09/2025 | $15,055,000 | -0.2% | 1,501,000 | 0.0% | 1.20% | -13.4% | |
| REPL | New | REPLIMUNE GROUP INC | $14,583,000 | – | 491,998 | +100.0% | 1.17% | – |
| GRCL | New | GRACELL BIOTECHNOLOGIES INCsponsored ads | $11,812,000 | – | 851,638 | +100.0% | 0.94% | – |
| RGNX | Sell | REGENXBIO INC | $9,885,000 | -27.7% | 235,809 | -33.0% | 0.79% | -37.3% |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $9,328,000 | +139.7% | 951,814 | +64.6% | 0.75% | +107.8% |
| MTEM | MOLECULAR TEMPLATES INC | $9,220,000 | -14.2% | 1,374,047 | 0.0% | 0.74% | -25.5% | |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $7,350,000 | +12.9% | 408,329 | +10.1% | 0.59% | -2.0% |
| SRRK | SCHOLAR ROCK HLDG CORP | $5,151,000 | +14.3% | 156,000 | 0.0% | 0.41% | -1.0% | |
| IMVT | Buy | IMMUNOVANT INC | $5,090,000 | +89.6% | 585,759 | +130.6% | 0.41% | +64.1% |
| APTX | APTINYX INC | $4,407,000 | -17.3% | 1,883,244 | 0.0% | 0.35% | -28.3% | |
| EPZM | EPIZYME INC | $3,786,000 | -38.4% | 739,369 | 0.0% | 0.30% | -46.6% | |
| ALNA | ALLENA PHARMACEUTICALS | $3,005,000 | -30.6% | 3,330,373 | 0.0% | 0.24% | -39.8% | |
| EPIX | Buy | ESSA PHARMA INC | $2,867,000 | -68.3% | 358,346 | +13.2% | 0.23% | -72.5% |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $2,736,000 | – | 156,807 | +100.0% | 0.22% | – |
| BLU | Sell | BELLUS HEALTH INC NEW | $2,649,000 | -34.3% | 433,247 | -66.6% | 0.21% | -43.0% |
| GRTX | GALERA THERAPEUTICS INC | $1,952,000 | -17.6% | 241,000 | 0.0% | 0.16% | -28.4% | |
| FRLN | FREELINE THERAPEUTICS HLDGSsponsored ads | $1,876,000 | -58.2% | 550,000 | 0.0% | 0.15% | -63.7% | |
| NABRIVA THERAPEUTICS PLC | $507,000 | -11.8% | 425,650 | 0.0% | 0.04% | -22.6% | ||
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -2,082,789 | -100.0% | -5.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL INC | 21 | Q4 2020 | 37.0% |
| ANAPTYSBIO INC | 20 | Q4 2021 | 63.7% |
| CIDARA THERAPEUTICS INC | 20 | Q3 2020 | 17.2% |
| IOVANCE BIOTHERAPEUTICS INC | 19 | Q4 2021 | 13.7% |
| ALLENA PHARMACEUTICALS INC | 18 | Q1 2022 | 11.9% |
| ALPINE IMMUNE SCIENCES INC | 18 | Q4 2021 | 9.1% |
| APTINYX INC | 15 | Q4 2021 | 16.9% |
| KRYSTAL BIOTECH INC | 14 | Q4 2021 | 9.7% |
| GRITSTONE ONCOLOGY INC | 14 | Q4 2021 | 8.2% |
| SIERRA ONCOLOGY INC | 12 | Q4 2019 | 6.6% |
View FRAZIER MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-08 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
| 13F-HR | 2021-05-12 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-04 |
View FRAZIER MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.